Compare AME & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AME | IDXX |
|---|---|---|
| Founded | 1930 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.7B | 57.1B |
| IPO Year | 1998 | 1996 |
| Metric | AME | IDXX |
|---|---|---|
| Price | $235.92 | $636.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $226.20 | ★ $715.00 |
| AVG Volume (30 Days) | ★ 1.3M | 481.4K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 0.56% | N/A |
| EPS Growth | 7.93 | ★ 22.59 |
| EPS | 6.40 | ★ 13.08 |
| Revenue | ★ $7,401,116,000.00 | $4,303,702,000.00 |
| Revenue This Year | $8.94 | $10.81 |
| Revenue Next Year | $5.57 | $8.62 |
| P/E Ratio | ★ $37.77 | $48.74 |
| Revenue Growth | 6.63 | ★ 10.42 |
| 52 Week Low | $151.14 | $356.25 |
| 52 Week High | $241.97 | $769.98 |
| Indicator | AME | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 42.40 |
| Support Level | $225.97 | $620.03 |
| Resistance Level | $239.94 | $655.87 |
| Average True Range (ATR) | 5.34 | 18.66 |
| MACD | -0.25 | 2.78 |
| Stochastic Oscillator | 57.38 | 47.42 |
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.